title: DNA-topoisomerase I and II: biologic features and their role in drug resistance.
authors.forename: D
authors.initials: D
authors.lastname: Russo
authors.forename: J P
authors.initials: JP
authors.lastname: Marie
authors.forename: A
authors.initials: A
authors.lastname: Delmer
authors.forename: D
authors.initials: D
authors.lastname: Zhou
authors.forename: A M
authors.initials: AM
authors.lastname: Suberville
authors.forename: M
authors.initials: M
authors.lastname: Baccarani
authors.forename: R
authors.initials: R
authors.lastname: Zittoun
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology / Q000627:therapeutic use; D002455:Cell Division; D004247:DNA / Q000378:metabolism; D004264:DNA Topoisomerases, Type I / Q000502:physiology*; D004250:DNA Topoisomerases, Type II / Q000502:physiology*; D004351:Drug Resistance; D006801:Humans; D007527:Isoenzymes / Q000037:antagonists & inhibitors / Q000502:physiology; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000188:drug therapy / Q000201:enzymology; D051379:Mice; D051381:Rats; D059004:Topoisomerase I Inhibitors; D059005:Topoisomerase II Inhibitors; D014407:Tumor Cells, Cultured
chemical_list: D000970:Antineoplastic Agents; D007527:Isoenzymes; D059004:Topoisomerase I Inhibitors; D059005:Topoisomerase II Inhibitors; D004247:DNA; D004264:DNA Topoisomerases, Type I; D004250:DNA Topoisomerases, Type II